JATT III Acquisition Corp (JTTT)
| Market Cap | 84.90M |
| Revenue (ttm) | n/a |
| Net Income | n/a |
| EPS | n/a |
| Shares Out | 7.73M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 4,170 |
| Open | 11.21 |
| Previous Close | 11.10 |
| Day's Range | 10.92 - 11.21 |
| 52-Week Range | 10.80 - 11.95 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About JTTT
JATT III Acquisition Corp is a blank check company. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was incorporated in 2026 and is based Westfield, New Jersey.
News
JATT III Acquisition Corp opens at $11, IPO priced at $10 per share
JATT III Acquisition Corp (JTTT) announced the pricing of its initial public offering of 6M ordinary shares at an offering price of $10.00 per ordinary share. The ordinary shares trade…
JATT III Acquisition Corp Announces Pricing of $60,000,000 Initial Public Offering
JATT III Acquisition Corp, a newly organized special purpose acquisition company...
SPAC JATT III Acquisition files for a $60 million IPO, following prior SPACs deal with Talawar Therapeutics
JATT III Acquisition, a blank check company formed by biotech entrepreneurs targeting life sciences businesses, filed on Monday with the SEC to raise up to $60 million in an initial public offering.
JATT III Acquisition IPO Registration Document (S-1)
JATT III Acquisition has filed to go public with an IPO on the NASDAQ